Table 1.
Clinical profiles of study subjects
Patient | VL (HIV RNA copies per ml) | CD4+, Tc/μl | CD8+, Tc/μl | CD4:CD8 Tc ratio | ART |
---|---|---|---|---|---|
1 | <50 | 143 | 2,264 | 0.06 | Y |
2 | <50 | 592 | 1,613 | 0.37 | Y |
3 | 24,618 | 422 | 991 | 0.43 | N |
4 | 203,495 | 369 | 819 | 0.45 | N |
5 | 58,791 | 143 | 1,378 | 0.10 | N |
6 | 29,870* | 672 | 1,071 | 0.63 | N |
7 | 123,000* | 317 | 337 | 0.94 | N |
8 | 62,000* | 517 | 873 | 0.59 | N |
9 | <10,000* | 798 | 495 | 1.61 | N |
10 | 13,760* | 767 | 2,013 | 0.38 | N |
11 | 50,725* | 394 | 816 | 0.48 | N |
ART, antiretroviral therapy; Tc, T cells.
*VL measured using assays with a limit of detection of 10,000 HIV RNA copies per ml.